CFO appointment
LB Pharmaceuticals Inc appoints Joseph M. Miller as CFO
LB Pharmaceuticals Inc reported in a Form 8-K filed September 3, 2026 that Joseph M. Miller was appointed Chief Financial Officer, effective September 2, 2026.
In the filing's words
On September 3, 2026, LB Pharmaceuticals Inc (the “Company”) announced that Joseph M. Miller has been appointed to serve as the Company’s Chief Financial Officer, effective as of September 2, 2026 (the “Start Date”).
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | LB Pharmaceuticals Inc (LBRX) |
|---|---|
| Event | Appointment |
| Incoming | Joseph M. Miller |
| Title in the filing | Chief Financial Officer |
| Effective | September 2, 2026 |
| 8-K filed | September 3, 2026 |
| Internal promotion | No |
| Prior role (per filing) | Chief Financial Officer, Aurinia Pharmaceuticals Inc. |
| SEC CIK | 0001691082 |
LB Pharmaceuticals Inc reported this change in a Form 8-K, Item 5.02, filed September 3, 2026. The filing's own words are quoted above.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Joseph M. Miller? Send a correction with the primary source.